New strategy to treat multiple sclerosis shows promise in mice
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.
One of the newly identified compounds, a Parkinson’s disease drug called benztropine, was highly effective in treating a standard model of MS in mice, both alone and in combination with existing MS therapies.
via Tumblr http://ift.tt/1idAH4n June 08, 2014 at 07:06PM
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου